Global Small Molecule API market is expected to reach $ 279,687.1 million by 2027
Global Small Molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period.
Pune, India – June 29, 2017 /MarketersMedia/ —
Introduction:
The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period. The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others.
Do Inquiry Before Purchasing Report Here: https://market.biz/report/global-small-molecule-api-market-mrf/102079/#inquiry
The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions.
Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016.
Key Findings
1) On the basis of types, synthetic/chemical API accounted for the largest market share of 81.31 % in 2016.
2) US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period.
Key Players
The leading players of the Global Small Molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy*s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others.
Target Audience
1) Small molecule API companies
2) Raw Material Suppliers
3) Key executive (CEO and COO) and strategy growth manager
About Us:
Market.Biz consists of a highly motivated team of young and experienced individuals who are detail-oriented and highly focused on providing clients with the information they need. Information is king in the business world, and we specialize in providing that.
Referal News Network: http://bantenpress.com
Contact Info:
Name: Lawrence John
Email: inquiry@market.biz
Organization: Market.Biz
Address: S no. 51/14 First Floor, Office Number 4, Vishwa Arcade, Near Navale Lawns, Pune, Maharashtra, India 411041.
Phone: +1(857)2390696
For more information, please visit https://market.biz/report/global-small-molecule-api-market-mrf/102079/
Source: MarketersMedia
Release ID: 212612
Copyright © 1999-2013 SproutNews.com
